M. Khalil

发表

Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis

I. Goldberg, W. Wagner, M. Khalil, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Atherosclerosis Molecular Interactions Leading to Lipoprotein Retention and the Initiation of

I. Goldberg, W. Wagner, M. Khalil, 2004 .

Neoadjuvant Immunotherapy in Microsatellite-Instability High Nonmetastatic Colorectal Cancer: A Single-institute Experience and Review of the Literature.

M. Khalil, R. Kinney, 2020, Clinical colorectal cancer.

Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]).

Tsung-Teh Wu, D. Wigle, S. Alberts, 2021, European journal of cancer.

Hepatocellular carcinoma in an African American man with a noncirrhotic liver presented initially as an occipital mass.

Ming Liu, Zili He, M. Kalavar, 2005, Clinical advances in hematology & oncology : H&O.

Anaplastic transformation of thyroid cancer: Report of two cases and review of the literature

A. Mooradian, I. Salti, P. Salem, 1983, Journal of surgical oncology.

Epithelioid Angiosarcoma of the Small Intestine After Occupational Exposure to Radiation and Polyvinyl Chloride: A case Report and Review of Literature

M. Rubin, R. Taub, M. Khalil, 2005, Sarcoma.

Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

I. Ostrovnaya, G. Iyer, H. Al-Ahmadie, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Discordant tumor response in the treatment of ALK-rearranged non-small cell lung cancer leads to the diagnosis of synchronous multiple primary lung cancer

M. Khalil, B. Johnson, 2013 .

Investigating the prognostic value of KOC (K homology domain containing protein overexpressed in cancer) overexpression after curative intent resection of pancreatic ductal adenocarcinoma.

H. Kirchner, Shaobo Zhu, J. Blansfield, 2016, Journal of gastrointestinal oncology.

Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

R. Schilsky, A. Alva, C. Calfa, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Granulocytic Sarcoma (GS) as first manifestation of AML

Albeir Y. Mousa, M. Kalavar, M. Khalil, 2005 .

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

D. Berry, S. Cummings, E. Fung, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Neoadjuvant atezolizumab (A) with gemcitabine and cisplatin (GC) in patients (pts) with muscle-invasive bladder cancer (MIBC): A multicenter, single-arm, phase 2 trial.

I. Ostrovnaya, G. Iyer, H. Al-Ahmadie, 2021 .

Pembrolizumab (P) in patients (pts) with metastatic breast cancer (MBC) with high tumor mutational burden (HTMB): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

R. Schilsky, A. Alva, C. Calfa, 2019, Journal of Clinical Oncology.